Practical Guidance for Using Reversine as an Aurora Kinase Inhibitor

What This Product Solves

Reversine (6-N-cyclohexyl-2-N-(4-morpholin-4-ylphenyl)-7H-purine-2,6-diamine) is a structurally distinct small molecule inhibitor that specifically targets Aurora kinases A, B, and C. These kinases are essential serine/threonine enzymes orchestrating mitotic processes—centrosome maturation, spindle assembly, and microtubule-kinetochore attachment. By inhibiting these kinases, Reversine enables researchers to experimentally disrupt mitotic progression, thereby facilitating detailed studies of cell cycle checkpoints, cancer cell proliferation inhibition, and apoptosis induction in cancer cells (source: product_spec). Its use is established for in vitro mechanistic studies and in vivo murine models, especially in the context of cervical cancer research and Aurora kinase signaling pathway interrogation.

Reversine is not intended for diagnostic or therapeutic applications, and its use should be confined to scientific research environments with established protocols for handling cell-permeable mitotic kinase inhibitors.

Protocol Parameters

• assay: Aurora kinase A inhibition | value_with_unit: IC50 = 150 nM | applicability: in vitro kinase assays, cellular mitotic checkpoint modulation | rationale: Defines the concentration required for half-maximal inhibition, guiding initial dose selection for mechanistic studies | source_type: product_spec
• assay: Solubility in DMSO | value_with_unit: ≥19.65 mg/mL | applicability: stock solution preparation for cell-based assays | rationale: DMSO provides high solubility, enabling preparation of concentrated stocks and accurate serial dilutions | source_type: product_spec
• assay: Storage conditions | value_with_unit: solid at -20°C | applicability: long-term compound stability | rationale: Low-temperature storage minimizes degradation, preserves activity, and maintains reproducibility across experiments | source_type: product_spec
• assay: Solubility in ethanol | value_with_unit: ≥6.69 mg/mL (with warming and ultrasonic treatment) | applicability: alternate solvent use for specific assay designs | rationale: Ethanol can be used if DMSO is unsuitable, provided gentle warming and ultrasonication are applied to achieve desired concentration | source_type: product_spec
• assay: Solution stability | value_with_unit: use promptly, avoid long-term storage | applicability: working solution preparation | rationale: Prepared solutions are not stable for extended periods; fresh preparation ensures experimental consistency | source_type: product_spec

Workflow Setup and QC Checklist

1. Compound Handling: Upon receipt, verify blue ice shipment and store Reversine solid at -20°C immediately (product_spec).
2. Stock Solution Preparation: Dissolve Reversine in DMSO at concentrations up to ≥19.65 mg/mL, ensuring complete dissolution; for ethanol, use gentle warming and ultrasonication as per solubility guidance.
3. Aliquoting: Prepare single-use aliquots to minimize freeze-thaw cycles and prevent moisture exposure.
4. Working Solution: Dilute freshly into culture medium to reach target concentrations for Aurora kinase inhibition, considering IC50 values as a starting reference for cellular assays (e.g., 150 nM for Aurora A).
5. Controls: Include vehicle-only controls (DMSO or ethanol) in all experimental arms to account for solvent effects.
6. Assay Compatibility: Confirm that the chosen solvent concentration does not exceed cytotoxic thresholds for the cell type or model system.
7. Documentation: Maintain detailed records of batch numbers, preparation dates, and solution handling steps to support reproducibility.
8. Degradation Prevention: Discard any unused working solution after each session; do not store solutions for future use.

For advanced protocols leveraging Reversine in high-content screening or cell cycle checkpoint assays, refer to internal articles like "Reversine and the Next Era of Aurora Kinase Inhibition", which expands on workflow design and troubleshooting. Additional technical insights on mitotic checkpoint manipulation are available in "Reversine: Unraveling Aurora Kinase Pathways in Cancer Cells".

Common Failure Modes and Fixes

• Poor Solubility: If undissolved particulates are observed, confirm correct solvent and concentration. For ethanol, employ gentle warming and ultrasonic treatment as described in the product specification.
• Loss of Activity: Avoid repeated freeze-thaw cycles and prolonged storage of solutions. Always use freshly prepared working dilutions and store the solid form at -20°C.
• Cellular Toxicity: Excessive solvent (DMSO or ethanol) can induce off-target effects. Validate final solvent concentration in your assay system and run matched vehicle controls.
• Batch-to-Batch Variability: Trace all experimental runs to specific product batches; monitor for changes in potency or solubility and consult APExBIO if inconsistencies arise.

Scope and Limitations

Reversine is validated for in vitro and selected in vivo research applications, particularly in cancer biology and the study of Aurora kinase signaling pathways. Its primary use cases include mechanistic studies of mitotic checkpoint control, cancer cell proliferation inhibition, and apoptosis induction in cancer cells. The product specification does not support its application in diagnostic procedures, clinical settings, or studies outside of mitotic regulation. Solubility is limited to DMSO and ethanol under specified conditions; aqueous solubility is not supported. Long-term solution storage is discouraged due to stability constraints (source: product_spec).

Researchers should not extrapolate use to unrelated biological systems or therapeutic environments without additional validation. Only apply Reversine in workflows designed for cell-permeable Aurora kinase A, B, and C inhibitors as per established literature and product recommendations.

Conclusion

Reversine provides a rigorously characterized, research-grade tool for dissecting Aurora kinase function in cancer models and cell cycle studies. Adherence to product-specific parameters—solubility, storage, and handling—ensures data integrity and reproducibility. For further workflow integration or troubleshooting, product documentation and relevant internal articles offer detailed guidance for maximizing experimental outcomes.